U.S. says Shire subsidiaries to pay $350 mln to settle false claims act allegations
WASHINGTON Jan 11 Shire PLC subsidiaries will pay $350 million to settle U.S. federal and state False Claims Act allegations related to unlawful methods to push "Dermagraft," a treatment for diabetic foot ulcers, the U.S. Justice Department said in a statement on Wednesday.
"The settlement resolves allegations that Dermagraft salespersons unlawfully induced clinics and physicians with lavish dinners, drinks, entertainment and travel; medical equipment and supplies; unwarranted payments for purported speaking engagements and bogus case studies; and cash, credits and rebates, to induce the use of Dermagraft," it said. (Reporting by Washington Newsroom; Editing by Chizu Nomiyama)
BRIEF-Toshiba chip chief: Western Digital's offer for chip unit has anti-monopoly issues, valuation not high
June 28 Toshiba Corp chip business chief Yasuo Naruke: